Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.
Cell Mol Immunol. 2021 Oct;18(10):2455-2456. doi: 10.1038/s41423-021-00755-z. Epub 2021 Aug 23.
Cell Mol Immunol. 2021.
PMID: 34426672
Free PMC article.
No abstract available.
Dalbavancin: novel candidate for COVID-19 treatment.
Hoffmann M, Jin Y, Pöhlmann S.
Hoffmann M, et al.
Cell Res. 2021 Mar;31(3):243-244. doi: 10.1038/s41422-020-00459-5.
Cell Res. 2021.
PMID: 33473156
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite